BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director

BioGene Therapeutics Inc. has announced the appointment of Raj S. Pruthi, MD, MHA, FACS, as its new Director. The announcement was made on March 12, 2026. Dr. Pruthi brings extensive experience in healthcare leadership and clinical expertise to the role.

Dr. Pruthi holds a Doctor of Medicine (MD), a Master of Healthcare Administration (MHA), and is recognized as a Fellow of the American College of Surgeons (FACS). His professional background includes significant contributions to medical research and healthcare management. BioGene Therapeutics Inc., which operates in the biotechnology sector, stated that this appointment aligns with its ongoing efforts to strengthen its leadership team and advance its organizational goals.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: March 12, 2026

Author

GOAI